Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-014915
Filing Date
2015-02-17
Accepted
2015-02-17 20:27:31
Documents
2
Period of Report
2015-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5586
2 EX-24 DOCUMENT attachment1.htm EX-24 4591
  Complete submission text file 0001209191-15-014915.txt   11749
Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address ONE MEDIMMUNE WAY GAITHERSBURG MD 20878 301-398-0000
MedImmune Ventures, Inc. (Reporting) CIK: 0001291884 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36829 | Film No.: 15625544